Drug Topics
NOVEMBER 7, 2023
A Q&A with Ginny Langbehn, vice president of marketing and communications at American Associated Pharmacies, about different strategies pharmacies can use to bring in new customers.
Pharmacy Times
NOVEMBER 7, 2023
AI may help to significantly speed up drug discovery and development, and help researchers end the treatment-resistant infection crisis before it’s too late.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 7, 2023
More than two dozen attorneys general are urging Food and Drug Administration officials to take urgent action to address disparities in how well pulse oximeters, the fingertip devices used to monitor a person’s oxygen levels, work on people with darker skin. In a Nov. 1 letter, the AGs noted that it had been a year since the FDA convened a public meeting of experts , who called for clearer labeling and more rigorous testing of the devices, and that no action had been taken.
Pharmacy Times
NOVEMBER 7, 2023
With appointment-based models in community pharmacy, researchers have noted that community pharmacies are well suited for identifying and addressing social determinants of health.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
NOVEMBER 7, 2023
The number of babies born with congenital syphilis in the United States has soared over the last decade, leading to an increase in stillbirths, infant deaths, and life-altering birth defects, the Centers for Disease Control and Prevention reported Tuesday. The number of cases of congenital syphilis in 2022 was more than 10 times the number recorded in 2012, the agency said, noting that most of the 3,761 cases reported in 2022 could have been averted, if the babies’ mothers had been adequa
Pharmacy Times
NOVEMBER 7, 2023
Investigators found that there was no association of dementia incidence in insulin use at 5 years after stopping metformin and an association at 0.07 years for HbA1C level at year 1.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
NOVEMBER 7, 2023
Infants younger than 6 months old are the highest risk for severe RSV infection, so researchers aim to target this group for prevention methods
STAT
NOVEMBER 7, 2023
Over the past few years, researchers have started using AI to capture signals from our voices in hopes of quickly diagnosing diseases. Academics and startup founders in the nascent field talked about the potential benefits, as well as the privacy implications, of this technology at the Milken Institute Future of Health Summit on Tuesday. “There’s a very rich set of data for us to look at,” said Nate Blaylock, chief technology officer at voice AI company Canary Speech.
Pharmacy Times
NOVEMBER 7, 2023
With precision medicine, patients undergoing treatment are living longer without disease recurrence or progression and with fewer adverse effects, resulting in preservation of quality of life.
STAT
NOVEMBER 7, 2023
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your inbox on Tuesdays and Thursdays. On the hot seat, feeling the Bern Drug executives will soon have the chance to tell Congress why they’re suing Medicare over price negotiations when their companies sell drugs to all the other governments that negotiate prices, my colleague John Wilkerson reports.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Pharma
NOVEMBER 7, 2023
Pharma, you were warned. | Only two months after the Federal Trade Commission said it was eying a crackdown on improper patents listed by the FDA, the agency has filed challenges against more than 100 patents in the agency's Orange Book. The companies have 30 days to respond.
STAT
NOVEMBER 7, 2023
WASHINGTON — The pandemic showed how fragile the supply chain can be, and to fix it, the United States needs to treat health care like a national security issue, said experts at a health conference here on Monday. Rep. Debbie Dingell (D-Mich.), speaking on a panel at the Milken Institute’s Future of Health Summit, warned that if the country had another pandemic or faced a bacterial biowarfare threat, “and we don’t have the capability to produce antibiotics in our coun
Fierce Healthcare
NOVEMBER 7, 2023
Hims & Hers' strong revenue growth streak continued in the third quarter as the digital health and wellness business brought in $227 million, up 57% from a year ago. | With continued strong revenue growth, Hims & Hers expects to be profitable by the first half of 2024. The digital health and wellness company boosted its revenue outlook for the year and announced a new AI-powered service to personalize treatments.
STAT
NOVEMBER 7, 2023
During the pandemic, in search of tools to keep patients healthy and virus-free, doctors turned to a new technology for help: remote patient monitoring. In 2020, home use of tools like connected blood pressure cuffs, continuous glucose monitors, and weight scales shot up, with billing for the devices and their associated care more than quadrupling. As use of remote patient monitoring has continued to grow — albeit at a slower rate than during the early-pandemic surge — data on its
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
NOVEMBER 7, 2023
The FDA is advising health care professionals who administer the vaccine to make sure the correct volume of the vaccine is withdrawn from the vial and the correct dose is administered to the patient.
The Guardian - Pharmaceutical Industry
NOVEMBER 7, 2023
Cure any ailment! Never known to fail! Early medicine adverts made grand claims but they look alarming today The confusion with patent medicines starts with the name, since they were rarely ever patented; manufacturers just thought it sounded cool. Bamboozling was always part of the package: from the 17th century, concoctions of water, alcohol and herbs were sold with wild claims and exotic origin stories.
Drug Topics
NOVEMBER 7, 2023
According to a presentation at AMCP Nexus 2023, a pharmacist-led program initiated by the Mayo Clinic improved access and lowered costs for patients by promoting biosimilar adoption.
Fierce Pharma
NOVEMBER 7, 2023
Pfizer’s $3.5 billion cost-savings drive has made its way overseas. | The layoffs at Pfizer's Newbridge, Kildare, manufacturing site are the latest in the company's effort to save $3.5 billion by 2024 amid declining demand for its COVID-19 products.
STAT
NOVEMBER 7, 2023
After years of trying, the Food and Drug Administration is again seeking to withdraw approval of an antibiotic that is widely used by farmers to control diarrhea in their pigs, but has generated controversy over links to cancer. At issue is carbadox , which, since the 1970s, has been added to livestock feed to combat diarrhea in young pigs after they are weaned from their mothers, as well as to promote growth.
Drug Topics
NOVEMBER 7, 2023
Understanding critical risk factors associated with the use of electronic nicotine delivery systems (ENDS) may help mitigate the harm dealt to youths by such devices.
STAT
NOVEMBER 7, 2023
Kindbody, a fast-growing fertility chain, knowingly exposed countless eggs and embryos to unsafe conditions and suffered repeated embryo mix-ups, according to a months-long Bloomberg investigation published recently. Here we go again.
pharmaphorum
NOVEMBER 7, 2023
Frontiers Health 23 - Day 1 from the marvellous Auditorium della Tecnica in Rome, where we are set to bring you the biggest news stories, trends, and industry insights
Fierce Pharma
NOVEMBER 7, 2023
There might just be a silver lining for Johnson & Johnson in the FDA's recent approval of Amgen’s Stelara biosimilar. | There might just be a silver lining for Johnson & Jonhson in the FDA's recent approval of Amgen’s Stelara biosimilar. That’s because the coming entry of a cheaper copycat presents J&J with an opportunity to elude Medicare price negotiations outlined in the Inflation Reduction Act.
pharmaphorum
NOVEMBER 7, 2023
In this week’s episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Raquel Izumi, chief operating officer and co-founder of Vincerx Pharma, who is on a mission to improve antibody drug conjugate (or ADC) drug development, aiming to conquer cancer with safe, well-tolerated, and paradigm-shifting therapeutics.
STAT
NOVEMBER 7, 2023
WASHINGTON — Current and former government officials proffered a clear-eyed, and often depressing, take Tuesday on the state of clinical trials, the pharmaceutical industry, and biotech investors coming out of the Covid-19 pandemic. The officials, including the Food and Drug Administration’s second-in-command Janet Woodcock, acknowledged the drug industry’s persistent lack of interest in collaborating on clinical trials, the ways hypercompetition pervades academic research a
PharmExec
NOVEMBER 7, 2023
Due to a higher than anticipated demand, Sanofi is carefully managing distribution of 50 mg doses of Beyfortus in the private market to fulfill existing orders and provide equitable access to remaining doses for the vaccine that protects infants against respiratory syncytial virus.
Fierce Pharma
NOVEMBER 7, 2023
Two long-awaited treatments for sickle cell disease (SCD) are on the docket for FDA decisions next month. Vertex and CRISPR Therapeutics are up first with a Dec. | Two long-awaited treatments for sickle cell disease (SCD) are on the docket for FDA decisions next month. One potential advantage for bluebird, giving the timing, could be a chance to view its rival's pricing before deciding itself.
STAT
NOVEMBER 7, 2023
WASHINGTON (AP) — As U.S. doctors scale back their use of opioid painkillers , a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy. Prescriptions for ketamine have soared in recent years, driven by for-profit clinics and telehealth services offering the medication as a treatment for pain, depression, anxiety and other conditions.
The Checkup by Singlecare
NOVEMBER 7, 2023
If you’ve recently been diagnosed with diabetes or pre-diabetes, your healthcare provider will likely recommend regular checks of your A1C levels. This is done with a hemoglobin A1C blood test, also known as the glycated hemoglobin, glycohemoglobin, or HbA1C test. By measuring how many red blood cells have glucose attached to them, the test is used to assess blood sugar levels over time.
STAT
NOVEMBER 7, 2023
Making good on a recent threat, the Federal Trade Commission is challenging more than 100 patents on brand-name medicines that were improperly or inaccurately listed by some of the world’s biggest drug companies in a key government registry. The agency notified 10 companies that listings for dozens of patents on such medicines as asthma inhalers and epinephrine autoinjectors are being disputed.
Fierce Pharma
NOVEMBER 7, 2023
Armed with dwarfism med Voxzogo and hemophilia A gene therapy Roctavian, BioMarin Pharmaceutical recently turned a corner into profitability after many years operating at a loss. | Armed with dwarfism med Voxzogo and hemophilia A gene therapy Roctavian, BioMarin recently turned a corner into profitability after many years operating at a loss. Now, the drugmaker has reportedly garnered the attention of activist investor Elliott Management.
pharmaphorum
NOVEMBER 7, 2023
Søren Møller, managing partner for seed investments at Novo Holdings, has successfully supported numerous healthcare startups through strategic investments.
Fierce Pharma
NOVEMBER 7, 2023
Before Sage and Biogen’s Zurzuvae (zuranolone) won approval from the FDA for postpartum depression (PPD) in August, the companies had said that the highly anticipated first-in-class treatment would | Before Sage and Biogen’s Zurvuvae was approved by the FDA for postpartum depression in August, the companies had said that the highly anticipated treatment would be available for less than $10,000.
Pharmacy Times
NOVEMBER 7, 2023
Pricing is also a key issue, as many insurance plans do not cover these medications’ use for obesity.
Expert insights. Personalized for you.
211 
Let's personalize your content